Cardiol Therapeutics Inc 6-K, filed Mar 14, 2025
Cardiol Therapeutics Inc. (CRDL)
About this 6-K
Cardiol Therapeutics Inc filed this 6-K on March 14, 2025.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of March 2025
Commission File Number: 001-40712
Cardiol Therapeutics Inc.
(Name of registrant)
602-2265 Upper Middle Road East
Oakville, Ontario L6H 0G5
Canada
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
| ¨ Form 20-F | x Form 40-F |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| CARDIOL THERAPEUTICS INC. | |||
| (Registrant) | |||
| Date: March 14, 2025 | By: | /s/ Chris Waddick | |
| Name: | Chris Waddick | ||
| Title: | Chief Financial Officer | ||
Form 6-K Exhibit Index
| Exhibit Number |
Document Description | |
| 99.1 | Notice of Meeting and Record Date, dated March 14, 2025 |
Exhibit 99.1
| March 14, 2025 |  |
Filed via SEDAR+
To All Applicable Exchanges and Securities Administrators
| Subject: | Cardiol Therapeutics Inc. (the "Issuer") |
| Notice of Meeting and Record Date |
Dear Sir/Madam:
We are pleased to confirm the following information with respect to the Issuer's upcoming meeting of securityholders:
| Meeting Type: | Annual General Meeting |
| Meeting Date: | May 28, 2025 |
| Record Date for Notice of Meeting: | April 10, 2025 |
| Record Date for Voting (if applicable): | April 10, 2025 |
| Beneficial Ownership Determination Date: | April 10, 2025 |
| Class of Securities Entitled to Vote: | Class A Common |
| ISIN: | CA14161Y2006 |
| Issuer sending proxy materials directly to NOBOs: | No |
| Issuer paying for delivery to OBOs: | Yes |
| Notice and Access for Beneficial Holders: | Yes |
| Beneficial Holders Stratification Criteria: | Not Applicable |
| Notice and Access for Registered Holders: | Yes |
| Registered Holders Stratification Criteria: | Not Applicable |
In accordance with applicable securities regulations we are filing this information with you in our capacity as agent of the Issuer.
Yours truly,
Odyssey Trust Company
as agent for Cardiol Therapeutics Inc.